TrialResearch and practice in thrombosis and haemostasis2026

Efficacy and safety of recombinant von Willebrand factor in on-demand treatment of children with von Willebrand disease: up to 4 years of phase 3/3b follow-up.

Shayla Bergmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.